Mefoglipitin Duo Tablets 2.5/1000 mg

Adult dose

This medication is administered twice daily with meals. To reduce gastrointestinal side effects associated with metformin, dosage increases should be gradual. 1. For those with no prior experience of diabetes medication treatment and who have difficulty controlling blood sugar with monotherapy, an initial dose of 2.5/500 mg twice daily, taking 1 tablet per dose, is recommended, with the potential to increase to 2.5/1000 mg twice daily, 1 tablet at a time. 2. In cases where blood sugar control is insufficient with metformin monotherapy

This medication is used in the treatment of diabetes and helps control blood sugar levels. It should not be used in certain patients. For example, individuals who are allergic to this medication or its components, patients with type 1 diabetes, those with severe kidney impairment, patients with acute infections or dehydration, individuals with severely impaired liver function, and women who are pregnant or breastfeeding may be at risk if they take this medication. While taking this medication, one must be cautious of symptoms of hypoglycemia. Especially when taken together with other hypoglycemic agents or insulin, the risk of hypoglycemia may increase, so blood sugar levels should be monitored frequently, and medication dosages adjusted as necessary. Rare side effects such as lactic acidosis may occur, particularly in cases where kidney function declines rapidly or in the presence of heart disease, liver disease, or severe infections. Therefore, kidney function and overall health status should be regularly monitored, and symptoms should be reported to healthcare professionals immediately. Since this medication is excreted through the kidneys, elderly individuals or those with kidney disease must take extra caution and should undergo regular kidney function tests. Additionally, this medication may interact with some other drugs, so if there are other medications being taken, it is essential to inform the doctor or pharmacist, and dosage adjustment or monitoring may be required. In case of pregnancy or if planning to become pregnant, insulin therapy is recommended in place of this medication, and it is advisable not to use this medication during breastfeeding. It is not recommended for children and adolescents since its safety and efficacy have not been established. If severe abdominal pain, persistent vomiting, muscle weakness, or difficulty breathing occurs while taking this medication, consult a healthcare professional immediately. When storing this medication, keep it out of the reach of children, avoid moisture, and do not transfer it to another container.

Serious side effects

Urticaria, angioedema, lactic acidosis, severe allergic reactions, severe skin reactions, respiratory issues accompanied by cough and fever, liver issues (jaundice), hepatitis, sudden and severe headaches, seizures, confusion, vision changes, paralysis, acute pancreatitis, bullous pemphigoid, remarkably decreased urine output, severe swelling accompanied by high blood pressure, heart failure, acute myocardial infarction

Mild side effects

• Nasopharyngitis
• hypersensitivity
• vitamin B12 decrease and deficiency
• hypoglycemia
• taste disturbance
• cough
• decreased appetite
• diarrhea
• constipation
• nausea

This medication is sensitive to air and moisture, so it must be stored in a sealed container. It is also important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance

Bright pink, biconvex, oval-shaped film-coated tablets

Package unit

60 tablets/PTP [(10 tablets/PTP × 6)]